id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-E-3592-0003,FDA,FDA-2017-E-3592,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-08-03T04:00:00Z,2017,8,2017-08-03T04:00:00Z,,2017-08-03T14:32:23Z,,0,0,090000648299ad1f
FDA-2017-E-3592-0002,FDA,FDA-2017-E-3592,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2017-06-09T04:00:00Z,2017,6,2017-06-09T04:00:00Z,,2017-06-09T13:27:43Z,,0,0,09000064826aec10
FDA-2017-E-3592-0001,FDA,FDA-2017-E-3592,"Patent Extension Application from Squire Patton Boggs (US) LLP (on behalf of ABBOTT CARDIOVASCULAR SYSTEMS INC. (""ABBOTT""))",Other,Application,2017-06-08T04:00:00Z,2017,6,2017-06-08T04:00:00Z,,2017-06-09T14:11:04Z,,0,0,09000064826add3b